If I had $10,000 available for ASX growth shares today, I would be comfortable splitting it between the two businesses in this article whose share prices have fallen sharply.

Both still have plenty to prove, but I think the long-term opportunities remain substantial.

Here is where I would put the money.

Catapult Sports Ltd (ASX: CAT)

I would invest $5,000 into Catapult Sports.

Its shares may be down heavily from their highs, but I think the underlying opportunity in professional sport remains intact.

Professional sport is global, highly competitive, and increasingly willing to spend on anything that can improve preparation or decision-making.

Catapult develops technology used by elite sporting organisations to understand what is happening on the field, in training, and across an athlete’s wider performance.

What interests me is how deeply this technology can become embedded in a team’s decision-making. A club can use Catapult to measure physical workloads, review video, assess tactical patterns, and manage preparation. Over time, more of those functions can sit within the same technology ecosystem.

That gives Catapult room to grow by winning new customers and becoming more valuable to existing ones over the next decade and beyond.

SiteMinder Ltd (ASX: SDR)

My other $5,000 would go into SiteMinder, whose shares have also fallen heavily from their 52-week high.

This ASX growth share builds technology that sits behind hotel bookings.

Hotels need to make rooms available across multiple channels, manage pricing, encourage direct bookings, and keep inventory updated as reservations arrive. SiteMinder brings much of that together.

I think the long-term opportunity comes from the sheer number of accommodation providers that still have room to modernise how they sell rooms.

Running a hotel is already complicated enough without staff manually adjusting availability and pricing across numerous booking platforms. Better software can remove some of that work while helping operators reach more travellers.

SiteMinder is also developing more automated tools, including artificial intelligence capabilities that could help hotels respond to demand and manage distribution with less manual input.

If more accommodation providers decide their technology needs an upgrade, I think SiteMinder can become an increasingly important part of how hotels operate online.

Foolish takeaway

I would be comfortable putting $5,000 behind each of these ASX growth shares.

The recent falls do not remove the risks, and both companies still need to execute well. But I think Catapult Sports and SiteMinder are addressing markets that should keep becoming more technology-driven. 

At today’s lower share prices, I would be willing to back that opportunity with a long-term view.

The post Why I’d invest $10,000 into these ASX growth shares appeared first on The Motley Fool Australia.

More reading

• Where I’d invest $15,000 in ASX shares now
• 2 ASX shares tipped to grow 60% or more in the next 12 months
• Why I think this is a top ASX tech share to buy today
• SiteMinder: FY26 profit nearly doubles, revenue jumps 22%
• 3 ASX shares I’d buy for their global growth potential

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Sports and SiteMinder. The Motley Fool Australia has positions in and has recommended Catapult Sports and SiteMinder. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are up 0.4% to 9,039 points on Monday.

Among the 11 market sectors, energy is in the lead today, up 1.1%, while technology is the laggard, down 1.6%.

The financial sector led the market last week amid a bank share rally due to better-than-expected GDP data.

Let’s check out some new ratings on ASX shares today.

Megaport Ltd (ASX: MP1) 

The Megaport share price is $16.73, down 1.6% today and up 23% over 12 months. 

Ord Minnett has an accummulate rating on this ASX 200 tech share.

In a new note, the broker commented:  

Megaport’s (MP1) FY26 earnings and FY27 guidance exceeded consensus estimates. The company also announced three contract wins, together valued at $506 million. ‍

We believe the soft reaction to the results may have been because … ‍Some parts of the investment community had been expecting contract wins already, or more of a guidance uplift in guidance from GPU Pool monetisation.

We see guidance as prudent, and the EBITDA target is achievable purely on a conservative ramp-up of contracts without GPU Pool monetisation. 

Our target price is revised to $22. We have an Accumulate recommendation. Catalysts for the shares include upgrades to FY27 guidance and more contract wins.

Xero Ltd (ASX: XRO)

The Xero share price is $77.91, down 1.8% today and down 52% over 12 months. 

Blake Halligan from Gray Perry Wealth Advisers has a hold rating on this ASX 200 tech stock.

He said (courtesy The Bull):  

Xero remains a leading cloud accounting platform, with a dominant position in Australia and New Zealand.

Fiscal year 2026 operating revenue increased 31 per cent, supported by 506,000 net customer additions and the Melio Payments acquisition. Melio should aid in revenue growth, but costs associated with its integration contributed to a 27 per cent fall in net profit after tax and a gross margin decline from 89 per cent to 83.9 per cent.

The profitable ANZ and UK businesses offer growth potential and could assist in a continuing share price recovery.

AMP Ltd (ASX: AMP)

The AMP share price is $2.47, down 0.4% today and up 45% over 12 months. 

Halligan has a sell rating on this ASX 200 financial share.

He explained:

This wealth management company’s turnaround has gained momentum, with underlying net profit after tax (NPAT) increasing 33 per cent in the first half of 2026.

The simplified business, growing North platform and further capital returns are positives. However, much of this improvement appears reflected in the share price. AMP Bank also faces intense mortgage competition, higher funding costs and investment requirements.

The shares have risen from $1.16 on March 12 to trade at $2.475 on September 3.

The recent share price strength provides an opportunity to reallocate capital elsewhere, as restructuring and execution risks still remain.

The post Buy, hold, sell: Megaport, Xero, AMP shares appeared first on The Motley Fool Australia.

More reading

• These ASX 50 shares have lost up to 60%. Is the sell-off overdone?
• How to build a winning ASX share portfolio and create wealth
• ASX 200 bank shares led a financial sector rebound last week
• A 50% upside? This ASX 200 tech stock is back on my buy list
• This ASX 200 tech giant is down 30% in 2026. Can it make a comeback?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Bubs Australia Ltd (ASX: BUB) shares have returned from their trading halt with a bang on Monday.

At the time of writing, the infant formula stock is up 40% to 14 cents, after trading as high as 14.5 cents earlier this morning.

That is quite a turnaround. Bubs shares were down around 27% in 2026 when trading was halted on Friday. After today’s jump, the stock is now slightly higher for the year.

So, what has sent Bubs shares flying today?

The wait is finally over

According to the release, Bubs has secured permanent regulatory authorisation from the US Food and Drug Administration (FDA).

The approval covers 3 infant formula products: Bubs Goat, Bubs 365 Day Grass Fed, and Bubs Essential.

It confirms that the products, manufacturing systems, and supporting scientific evidence meet US requirements around safety, nutritional adequacy, and quality.

It also makes Bubs the only Australian infant formula brand, and one of a limited number of international manufacturers, permanently authorised to supply the US market.

CEO Joe Coote called it a “transformational milestone” and said the approval gives Bubs a platform to accelerate its US growth strategy.

The decision could also support a broader product range and possible entry into the US private-label infant nutrition market.

Why this is such a big deal

The US is already Bubs’ biggest market.

US revenue rose 24% to $65.8 million in FY26, out of total group revenue of $111.9 million. Its products are also now sold in more than 10,000 stores across the country.

Until now, Bubs had been able to continue selling in the US while the FDA worked through its review.

That process is now complete, removing one of the biggest uncertainties hanging over the business.

With well over half of group revenue now coming from the US, securing permanent approval is a major step for the company.

The director buying is worth a look

There’s another detail here that stands out.

Bubs chair Paul Jensen bought 1.5 million shares across 31 August and 1 September, paying between 8.55 cents and 8.7 cents per share.

In total, he spent around $130,500 just days before today’s FDA announcement.

And Jensen has been buying Bubs shares for some time. He also bought 1 million shares across 3 on-market trades in March, after picking up another 630,890 shares across 2 trades last September.

At today’s 14-cent share price, his latest 1.5 million shares are worth around $210,000. That’s roughly $80,000 more than he paid.

But he wasn’t the only director buying last week. Pascal De Petrini bought 800,000 shares, while Lori Tauber Marcus purchased her first 100,000 shares at 9.5 cents each.

The post Bubs shares just rocketed 40%. Here’s the news investors were waiting for appeared first on The Motley Fool Australia.

More reading

• This ASX share jumped 7% before a trading halt. What’s going on?
• How high do brokers think Bubs Australia shares will go?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.